The vast majority (89%) of those who attempted to get an in-person COVID-19 test in the past month say they were able to get one. Still 11% of those who tried to get such a test (4% of all adults) say they were unable to get an in-person test, and 23% (7% of all adults) say they had to wait two days or more to be tested.
Source: Kaiser Family Foundation
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more
